A NOVEL DNA METHYLATION-BASED SURROGATE BIOMARKER FOR LATENT SYSTEMIC INFLAMMATION
Helen Meier, Eric Klopack, Mateo Farina, Belinda Hernández, Colter Mitchell, Jessica Faul, Cathal McCrory, Eileen Crimmins · 2024
Read A NOVEL DNA METHYLATION-BASED SURROGATE BIOMARKER FOR LATENT SYSTEMIC INFLAMMATION by Helen Meier, Eric Klopack, Mateo Farina, Belinda Hernández, Colter Mitchell, Jessica Faul, Cathal McCrory, Eileen Crimmins (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11692862.txt.
Description
Helen Meier and seven co-authors published a study in 2024 on a DNA-based stand-in for long-term inflammation in the body. Chronic low-grade inflammation predicts disease and death, but blood chemistry is not always available in large population studies. Chemical marks on DNA can serve as a record that survives in stored samples.
The team built their surrogate from a hidden factor drawn from seven inflammation markers. The new score tracked each marker well in a national study of older Americans. It also predicted disability, multiple illnesses, and four-year death rates about as well as the blood-based factor itself. Studies with only DNA samples can now study inflammation's role in aging with more confidence.
Catalog record
| CREATOR | Helen Meier, Eric Klopack, Mateo Farina, Belinda Hernández, Colter Mitchell, Jessica Faul, Cathal McCrory, Eileen Crimmins |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |